MedPath

University of Glasgow

University of Glasgow logo
πŸ‡¬πŸ‡§United Kingdom
Ownership
Private
Established
1451-01-07
Employees
10K
Market Cap
-
Website
http://www.gla.ac.uk

Rosiglitazone Versus Theophylline in Asthmatic Smokers

Phase 2
Completed
Conditions
Asthma
Interventions
First Posted Date
2005-07-13
Last Posted Date
2010-01-27
Lead Sponsor
University of Glasgow
Target Recruit Count
79
Registration Number
NCT00119496
Locations
πŸ‡¬πŸ‡§

Asthma Research Group, Gartnavel General Hospital, Glasgow, Scotland, United Kingdom

PNU 166148 in Treating Patients With Metastatic Solid Tumors

Phase 1
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
First Posted Date
2004-06-17
Last Posted Date
2013-12-19
Lead Sponsor
University of Glasgow
Target Recruit Count
30
Registration Number
NCT00004076
Locations
πŸ‡¬πŸ‡§

Aberdeen Royal Infirmary, Aberdeen, Scotland, United Kingdom

πŸ‡¬πŸ‡§

Beatson Oncology Centre, Glasgow, Scotland, United Kingdom

Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial Cancer

Phase 3
Completed
Conditions
Ovarian Cancer
Primary Peritoneal Cavity Cancer
First Posted Date
2004-06-03
Last Posted Date
2013-12-19
Lead Sponsor
University of Glasgow
Target Recruit Count
1050
Registration Number
NCT00003998
Locations
πŸ‡¬πŸ‡§

C.R.C. Beatson Laboratories, Glasgow, Scotland, United Kingdom

Chemotherapy in Treating Patients With Solid Tumors

Phase 1
Completed
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
First Posted Date
2004-05-20
Last Posted Date
2013-12-19
Lead Sponsor
University of Glasgow
Target Recruit Count
35
Registration Number
NCT00003698
Locations
πŸ‡¬πŸ‡§

Mount Vernon Hospital, Northwood, England, United Kingdom

Dimethylxanthenone Acetic Acid in Treating Patients With Solid Tumors

Phase 1
Completed
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
First Posted Date
2004-05-20
Last Posted Date
2013-12-19
Lead Sponsor
University of Glasgow
Target Recruit Count
3
Registration Number
NCT00003697
Locations
πŸ‡¬πŸ‡§

Mount Vernon Hospital, Northwood, England, United Kingdom

Doxorubicin in Treating Women With Advanced Breast Cancer

Phase 2
Conditions
Breast Cancer
First Posted Date
2004-04-30
Last Posted Date
2013-12-19
Lead Sponsor
University of Glasgow
Target Recruit Count
25
Registration Number
NCT00003165
Locations
πŸ‡¬πŸ‡§

Cancer Research Campaign Clinical Trials Unit-Birmingham (CRCTU), Birmingham, England, United Kingdom

πŸ‡¬πŸ‡§

Weston Park Hospital, Sheffield, England, United Kingdom

πŸ‡¬πŸ‡§

Western General Hospital, Edinburgh, Scotland, United Kingdom

and more 3 locations

Bryostatin 1 in Treating Patients With Ovarian Epithelial Cancer

Phase 2
Completed
Conditions
Ovarian Cancer
First Posted Date
2003-05-08
Last Posted Date
2013-06-26
Lead Sponsor
University of Glasgow
Registration Number
NCT00004008
Locations
πŸ‡¬πŸ‡§

Royal Infirmary, Glasgow, Scotland, United Kingdom

πŸ‡¬πŸ‡§

Christie Hospital N.H.S. Trust, Manchester, England, United Kingdom

πŸ‡¬πŸ‡§

Weston Park Hospital, Sheffield, England, United Kingdom

and more 1 locations

Radiation Therapy in Preventing Metastatic Cancer in Patients Who Have Diagnostic Procedures to Identify Malignant Mesothelioma

Phase 3
Completed
Conditions
Malignant Mesothelioma
Perioperative/Postoperative Complications
First Posted Date
2003-01-27
Last Posted Date
2013-12-19
Lead Sponsor
University of Glasgow
Target Recruit Count
44
Registration Number
NCT00006231
Locations
πŸ‡¬πŸ‡§

Gartnavel General Hospitall, Glasgow, Scotland, United Kingdom

πŸ‡¬πŸ‡§

West of Scotland Cancer Centre, Glasgow, Scotland, United Kingdom

πŸ‡¬πŸ‡§

Stobhill General Hospital, Glasgow, Scotland, United Kingdom

Β© Copyright 2025. All Rights Reserved by MedPath